BIRC3 and BIRC5: multi‐faceted inhibitors in cancer
R Frazzi - Cell & bioscience, 2021 - Springer
Background The evasion from apoptosis is a common strategy adopted by most tumors, and
inhibitors of apoptosis proteins (IAPs) are among the most studied molecular and …
inhibitors of apoptosis proteins (IAPs) are among the most studied molecular and …
Chronic lymphocytic leukaemia
Chronic lymphocytic leukaemia (CLL) is a malignancy of CD5+ B cells that is characterized
by the accumulation of small, mature-appearing lymphocytes in the blood, marrow and …
by the accumulation of small, mature-appearing lymphocytes in the blood, marrow and …
2016 US lymphoid malignancy statistics by World Health Organization subtypes
Collectively, lymphoid neoplasms are the fourth most common cancer and the sixth leading
cause of cancer death in the United States. The authors provide contemporary lymphoid …
cause of cancer death in the United States. The authors provide contemporary lymphoid …
Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK's Haematological Malignancy Research Network
Background: Population-based information about cancer occurrence and survival are
required to inform clinical practice and research; but for most lymphomas data are lacking …
required to inform clinical practice and research; but for most lymphomas data are lacking …
Chromosomal alterations among age-related haematopoietic clones in Japan
The extent to which the biology of oncogenesis and ageing are shaped by factors that
distinguish human populations is unknown. Haematopoietic clones with acquired mutations …
distinguish human populations is unknown. Haematopoietic clones with acquired mutations …
Impact of expert pathologic review of lymphoma diagnosis: study of patients from the French Lymphopath Network
Purpose To prospectively assess the clinical impact of expert review of lymphoma diagnosis
in France. Materials and Methods From January 2010 to December 2013, 42,145 samples …
in France. Materials and Methods From January 2010 to December 2013, 42,145 samples …
Racial and ethnic disparities in hematologic malignancies
Racial and ethnic disparities in patients with solid malignancies have been well
documented. Less is known about these disparities in patients with hematologic …
documented. Less is known about these disparities in patients with hematologic …
Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL
M Felices, B Kodal, P Hinderlie, MF Kaminski… - Blood …, 2019 - ashpublications.org
Chronic lymphocytic leukemia (CLL) is characterized by chronic clonal expansion of mature
CD19-expressing B lymphocytes and global dysfunction of immune effectors, including …
CD19-expressing B lymphocytes and global dysfunction of immune effectors, including …
Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice
JG Gribben, F Bosch, F Cymbalista… - British journal of …, 2018 - Wiley Online Library
Ibrutinib is indicated in Europe for the treatment of several B‐cell malignancies, including
chronic lymphocytic leukaemia (CLL). However, despite the high efficacy and favourable …
chronic lymphocytic leukaemia (CLL). However, despite the high efficacy and favourable …
[HTML][HTML] Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone
M Horvat, V Zadnik, T Južnič Šetina… - Oncology …, 2018 - spandidos-publications.com
Abstract Treatment with rituximab plus a regimen of cyclophosphamide, doxorubicin,
vincristine and prednisolone (CHOP) for patients with diffuse large B-cell lymphoma …
vincristine and prednisolone (CHOP) for patients with diffuse large B-cell lymphoma …